Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...
As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results